ABT

By Stephen Nakrosis

The U.S. Food and Drug Administration on Friday said it issued an emergency use authorization to Abbott Molecular Inc. for its monkeypox diagnostic test.

The authorization was issued for the Alinity m MPXV, a test intended to detect monkeypox DNA using lesion swab specimens from individuals suspected of infection, the FDA said.

The test is intended for use by qualified and trained clinical laboratory personnel, and testing is limited to certain laboratories, the FDA said.

According to the Centers for Disease Control, as of Sept. 30, there have been 26,049 cases of monkeypox reported in the U.S.

Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

(END) Dow Jones Newswires

October 07, 2022 17:09 ET (21:09 GMT)

Abbott Laboratories (NYSE:ABT)
Gráfico Histórico do Ativo
De Mai 2023 até Jun 2023

Abbott Laboratories (NYSE:ABT)
Gráfico Histórico do Ativo
De Jun 2022 até Jun 2023